ALPHAMAB-B (09966) Stock Price, News, Quotes-Moomoo

HK Stock MarketDetailed Quotes

09966 ALPHAMAB-B

Watchlist

4.310
-0.050-1.15%

Trading Nov 25 15:57 CST

4.15BMarket Cap-17591P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why Investors Shouldn't Be Surprised By Alphamab Oncology's (HKG:9966) 26% Share Price Surge
Simply Wall StNov 16 19:38 ET
Alphamab Oncology Presents Clinical Study Results for Tumor Treatment at Houston Cancer Meet
MT NewswiresNov 11 04:53 ET
Selected for LBA! The latest breakthrough clinical research results of Corning Jerry HER2 dual anti-ADC subcutaneous injection compound preparation JSKN033 will be presented at the 2024 SITC Annual Meeting.
On November 11, 2024 in Suzhou /PRNewswire/ -- Conic Jerry Biopharmaceutical (stock code: 9966.HK) announced that the first human clinical study results of the high-concentration subcutaneous injection compound preparation JSKN033 of HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 inhibitor were selected for the latest breakthrough abstracts at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in 2024.
PR NewswireNov 11 00:04 ET
Alphamab Oncology (HKG:9966) Has Debt But No Earnings; Should You Worry?
Simply Wall StNov 8 18:58 ET
Hong Kong stock market anomaly | Some pharmaceutical stocks rise, medical insurance negotiations support innovative drugs. Institutions point out that the sector still has further room for recovery.
Some pharmaceutical stocks rose, as of the deadline, SciClone Pharmaceuticals-B (02171) rose by 33.68% to HK$8.97; Concord Jingrui Pharmaceuticals-B (09966) rose by 10.34% to HK$4.27; LuPu Biotech-B (02157) rose by 7.87% to HK$3.29.
Zhitong FinanceNov 7 21:48 ET
Alphamab Oncology Receives Waivers for Company Secretary From Hong Kong Bourse
MT NewswiresOct 29 04:23 ET

Comments

Moomoo AI

Feb 7 00:43

Alphamab Oncology's high P/S ratio may not be justified due to weak revenue forecasts. Investors should remain cautious as this could negatively impact the share price.

Alphamab Oncology's (HKG:9966) 31% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Spinee

Jan 17 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

Moomoo AI

Dec 22, 2023 20:10

Due to Alphamab Oncology's slower growth rate compared to the industry and notably high P/S ratio, investors may face potential risks. The company's elevated stock price level may not be sustainable in light of its comparatively weak revenue outlook.

What Alphamab Oncology's (HKG:9966) P/S Is Not Telling You

Flord

Sep 24, 2021 05:26

$ALPHAMAB-B (09966.HK)$ If corning & Jerry's late-stage data can validate the early-stage data, it means that first-line treatment of NSCLC(MOS estimated at more than 25 months in phase II) can obtain MOS data much higher than K

Mikebierer

Sep 24, 2021 05:13

$ALPHAMAB-B (09966.HK)$ $KINTOR PHARMA-B (09939.HK)$ $INNOVENT BIO (01801.HK)$ Today Hong Kong pharmaceutical and biotech stocks fell 2.36%, industry groups in Hong Kong or top 5, kill the biological medicine market valuation, capital is still wary of innovative drug, exploit medicine, corning jerry that is called a fall, but has strong industry leading cinda biology, growth of 4.16% in the pharmaceutical sector in the first, Market money still likes and likes a few big champions.

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

09966 ALPHAMAB-B

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target